Distortion Product Otoacoustic Emissions in Cisplatin Administered Patients.
نویسندگان
چکیده
منابع مشابه
Distortion product otoacoustic emissions in tinnitus patients.
Tinnitus is a symptom that affects a great number of patients. Its diagnosis, treatment, and follow-up are difficult, owing to its subjectivity. The authors propose the use of distortion product otoacoustic emissions (DPOAEs) in tinnitus evaluation. They studied three groups: controls, having no complaint of tinnitus and normal hearing; group 1, presenting tinnitus and normal audiometry; and gr...
متن کاملDistortion-product otoacoustic emissions and auditory brainstem responses sensitivity assessment in cisplatin-induced ototoxicity in rats.
UNLABELLED Cisplatin (cis-diamminedicloroplatinum) is an antineoplastic drug used in the treatment of a variety of cancers, especially head-and-neck cancer. Its ototoxicity, however, has been noted as a common side-effect which limits its use and causes significant morbidity. AIM to assess distortion-product otoacoustic emissions (DPOAE) and brainstem evoked response audiometry (BERA) sensiti...
متن کاملOtoacoustic emissions growth rate threshold: distortion product in neonates.
BACKGROUND Distortion product otoacoustic emission measures (DPOAE) verifies, among other characteristics, the emergence and growth rate of the DPOAE response according to sound stimulus intensity (growth curve). AIM To estimate the DPOAE threshold in neonates according to the DPOAE growth curve at 2 kHz and 4 kHz, with stimulus presentation ranging between 35 and 70 dB SPL. METHOD Particip...
متن کاملFine Structure in Distortion Product Otoacoustic Emissions and Auditory Perception
4 The influence of the second source of distortion product otoacoustic emissions (DPOAE) on DPOAE input/output functions 41 INTRODUCTION 42 I. EXPERIMENTAL METHODS 45 A. Subjects 45 B. Instrumentation and signal processing 45 C. Calibration 46 D. DPOAE measurements 46 II. DATA ANALYSIS 47 A. Separation of DPOAE components via time windowing 47 B. DPOAE threshold according to Boege and Janssen 5...
متن کاملOtotoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
An objective method for identifying ototoxic hearing loss among patients receiving cisplatin is necessary since the ability of patients to take a behavioral test may change over the course of treatment. Data from 56 monitoring visits by 19 Veterans taking cisplatin were used to identify combinations of distortion-product otoacoustic emission (DPOAE) metrics and ototoxicity risk factors that bes...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: AUDIOLOGY JAPAN
سال: 1995
ISSN: 1883-7301,0303-8106
DOI: 10.4295/audiology.38.229